NO170800C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive, fluorerte arachidonsyrederivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive, fluorerte arachidonsyrederivater

Info

Publication number
NO170800C
NO170800C NO884905A NO884905A NO170800C NO 170800 C NO170800 C NO 170800C NO 884905 A NO884905 A NO 884905A NO 884905 A NO884905 A NO 884905A NO 170800 C NO170800 C NO 170800C
Authority
NO
Norway
Prior art keywords
fluorated
preparation
acid derivatives
arachidonic acid
therapeutic active
Prior art date
Application number
NO884905A
Other languages
English (en)
Norwegian (no)
Other versions
NO170800B (no
NO884905L (no
NO884905D0 (no
Inventor
Jean Bernard Ducep
Jean-Francoise Nave
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO884905D0 publication Critical patent/NO884905D0/no
Publication of NO884905L publication Critical patent/NO884905L/no
Publication of NO170800B publication Critical patent/NO170800B/no
Publication of NO170800C publication Critical patent/NO170800C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5428Acyclic unsaturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO884905A 1987-11-04 1988-11-03 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, fluorerte arachidonsyrederivater NO170800C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11716587A 1987-11-04 1987-11-04

Publications (4)

Publication Number Publication Date
NO884905D0 NO884905D0 (no) 1988-11-03
NO884905L NO884905L (no) 1989-05-05
NO170800B NO170800B (no) 1992-08-31
NO170800C true NO170800C (no) 1992-12-09

Family

ID=22371305

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884905A NO170800C (no) 1987-11-04 1988-11-03 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, fluorerte arachidonsyrederivater

Country Status (17)

Country Link
EP (1) EP0315166B1 (es)
JP (1) JP2799865B2 (es)
KR (1) KR0126134B1 (es)
CN (1) CN1032935A (es)
AT (1) ATE118757T1 (es)
AU (1) AU609535B2 (es)
CA (1) CA1333397C (es)
DE (1) DE3853126T2 (es)
DK (1) DK614688A (es)
ES (1) ES2070842T3 (es)
FI (1) FI885053A7 (es)
HU (1) HU199412B (es)
IL (1) IL88270A0 (es)
NO (1) NO170800C (es)
NZ (1) NZ226815A (es)
PT (1) PT88933B (es)
ZA (1) ZA888155B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2063152T3 (es) * 1989-05-02 1995-01-01 Merrell Dow Pharma Derivados fluorados de acido araquidonico.
PH31293A (en) * 1991-10-10 1998-07-06 Rhone Poulenc Agrochimie Production of y-linolenic acid by a delta6-desaturage.
CN101928229A (zh) * 2010-07-01 2010-12-29 黄冈华阳药业有限公司 生产左乙拉西坦的中间体l-2-氨基丁酰胺盐酸盐的工艺方法
CA2776178A1 (en) * 2012-04-05 2013-10-05 Hydro-Quebec Ionic compounds
CA2996706C (en) * 2015-08-27 2023-09-26 Universite D'angers Tocotrienol derivatives, pharmaceutical composition and method of use in 5-lipoxygenase related diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61271246A (ja) * 1985-05-25 1986-12-01 Asahi Glass Co Ltd 5−フレオロアラキドン酸誘導体およびその製造法
JPS61271234A (ja) * 1985-05-25 1986-12-01 Asahi Glass Co Ltd ビニルフルオリド誘導体およびその製造法

Also Published As

Publication number Publication date
PT88933A (pt) 1988-12-01
CN1032935A (zh) 1989-05-17
EP0315166A2 (en) 1989-05-10
KR890008073A (ko) 1989-07-08
AU609535B2 (en) 1991-05-02
HUT48194A (en) 1989-05-29
IL88270A0 (en) 1989-06-30
ES2070842T3 (es) 1995-06-16
NO170800B (no) 1992-08-31
JPH01151535A (ja) 1989-06-14
PT88933B (pt) 1993-01-29
EP0315166A3 (en) 1991-03-27
DK614688D0 (da) 1988-11-03
HU199412B (en) 1990-02-28
EP0315166B1 (en) 1995-02-22
NO884905L (no) 1989-05-05
NZ226815A (en) 1991-06-25
FI885053A0 (fi) 1988-11-02
DK614688A (da) 1989-05-05
NO884905D0 (no) 1988-11-03
ATE118757T1 (de) 1995-03-15
JP2799865B2 (ja) 1998-09-21
DE3853126T2 (de) 1995-06-14
FI885053A7 (fi) 1989-05-05
KR0126134B1 (ko) 1997-12-26
DE3853126D1 (de) 1995-03-30
AU2463688A (en) 1989-05-04
ZA888155B (en) 1989-07-26
CA1333397C (en) 1994-12-06

Similar Documents

Publication Publication Date Title
ATE119520T1 (de) Derivate von hydroxaminsäure und von n- hydroxyharnstoff sowie ihre verwendung.
FR2710527B1 (fr) Nouvelles compositions cosmétiques et dermatologiques associant céramides et acide linoléique, leur préparation.
ATE106867T1 (de) 13-trans-retinsäureester.
SE7903186L (sv) Cerebralverksamt medel
DK71387D0 (da) Terapeutisk middel til behandling af psoriasis
ATE85523T1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
NO884905L (no) Fremgangsmaate for fremstilling av fluorerte arachidonsyrederivater.
NO891703L (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
DE69329606D1 (de) 2,3-Bis-Carboxaamidomethyl substituierte Oxirane als Inhibitoren der HIV-Protease und ihre Verwendung zur Behandlung von AIDS Protease
NO922136D0 (no) Anvendelse av gibberelliner for behandling av prostatitisog psoriasis
NO173495C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fluorerte arachidonsyrederivater
ATE86492T1 (de) Anwendung von sterolinen und spiroketalinen zur herstellung von medikamenten zur behandlung von psoriasis.
ATE110714T1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
HU896587D0 (en) 2-amino-carbonic acid derivatives, and medical preparations containing them as active agents, and process for the production of the active agents and the preparation
NO178622C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive kynurensyrederivater, samt mellomprodukter egnet for fremstilling derav